Pancreatic Cancer Research

ResearcherPalacký University OlomoucNo recent work listed

Marina Hodolič

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5019739669. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper

Papers 3

  1. Safety and tolerability of 68Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, in patients with pancreatic ductal adenocarcinoma: the firs… Co-author DOI 10.1007/s00259-020-05045-w↗
  2. Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer. Co-author DOI 10.1097/mnm.0000000000001172↗
  3. Evidence of 68Ga-DOTA-NT-20.3 Uptake in Pancreatic Adenocarcinoma AsPC-1 Cell Line - in vitro Study. Last author DOI 10.2174/1389201019666180829152314↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stefano Fanti · 1 shared paper, 2020 · strength 0.19
  2. Feng Wang · 1 shared paper, 2021 · strength 0.16
  3. Irene Johanna Virgolini · 1 shared paper, 2021 · strength 0.16
  4. Angelica Facoetti · 1 shared paper, 2018 · strength 0.09
  5. Manuela Marenco · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.